Abraham Silji's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Mar 22, 2023
- Accession no.
- 0001562180-23-003040
- Filed
- Mar 22, 2023
- Trade date
- Mar 1-9, 2023
- Filing delay
- 21 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $483.9K. It was filed 21 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Abraham SiljiCIK 0001733001 | Officer (SVP, Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | AGrant or awardAcquired | +234 | $318.28 | +$74,477.52 | 5,709.3 | Direct | |
| Mar 9, 2023 | Common Stock | SSaleDisposed | −1,500 | $322.57 | −$483,855 | 4,209.3 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.